First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Pascal Joly; Maud Maho-Vaillant; Catherine Prost-Squarcioni; Vivien Hebert; Estelle Houivet; Sébastien Calbo; Frédérique Caillot; Marie Laure Golinski; Bruno Labeille; Catherine Picard-Dahan; Carle Paul; Marie-Aleth Richard; Jean David Bouaziz; Sophie Duvert-Lehembre; Philippe Bernard; Frederic Caux; Marina Alexandre; Saskia Ingen-Housz-Oro; Pierre Vabres; Emmanuel Delaporte; Gaelle Quereux; Alain Dupuy; Sebastien Debarbieux; Martine Avenel-Audran; Michel d'Incan; Christophe Bedane; Nathalie Bénéton; Denis Jullien; Nicolas Dupin; Laurent Misery; Laurent Machet; Marie Beylot-Barry; Olivier Dereure; Bruno Sassolas; Thomas Vermeulin; Jacques Benichou; Philippe Musette

doi:10.1016/S0140-6736(17)30070-3

Journal articles

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Pascal Joly Maud Maho-Vaillant Catherine Prost-Squarcioni Vivien Hebert Estelle Houivet Sébastien Calbo Frédérique Caillot Marie Laure Golinski Bruno Labeille Catherine Picard-Dahan Carle Paul Marie-Aleth Richard Jean David Bouaziz Sophie Duvert-Lehembre Philippe Bernard ¹ Frederic Caux Marina Alexandre Saskia Ingen-Housz-Oro Pierre Vabres Emmanuel Delaporte Gaelle Quereux Alain Dupuy Sebastien Debarbieux Martine Avenel-Audran Michel d'Incan Christophe Bedane Nathalie Bénéton Denis Jullien Nicolas Dupin Laurent Misery Laurent Machet Marie Beylot-Barry Olivier Dereure Bruno Sassolas Thomas Vermeulin Jacques Benichou Philippe Musette

1 IRMAIC - Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology

Complete list of metadata

https://hal.univ-reims.fr/hal-03604991
Contributor : Arnaud Pommier Connect in order to contact the contributor
Submitted on : Thursday, March 10, 2022 - 5:17:48 PM
Last modification on : Friday, March 11, 2022 - 3:12:35 AM

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Identifiers

Collections

Citation

Export

Metrics

2

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Identifiers

Collections

Citation

Export

Share

Metrics

2